Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Declining Comps Likely To Hurt Fred's (FRED) In Q3 Earnings

By Zacks Investment ResearchStock MarketsNov 29, 2017 09:18PM ET
www.investing.com/analysis/declining-comps-likely-to-hurt-freds-fred-in-q3-earnings-200269475
Declining Comps Likely To Hurt Fred's (FRED) In Q3 Earnings
By Zacks Investment Research   |  Nov 29, 2017 09:18PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
CVS
+1.92%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
WBA
-4.90%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
FREDQ
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
US902...
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Fred’s Inc (NASDAQ:FRED) is slated to report third-quarter fiscal 2017 results on Dec 6, before the opening bell.

We note that Fred’s delivered losses in the past five quarters. Further, the company has been struggling with murky comparable-store sales (comps).

While the company has a mixed record of bottom-line surprises in the trailing four quarters, let’s look into how things are shaping up for the upcoming announcement.

What to Expect?

The Zacks Consensus Estimate for the third quarter of fiscal 2017 is pegged at a loss of 15 cents, which has widened by a penny over the past 30 days. However, estimated loss for the quarter under review is lower than the prior year adjusted loss of 27 cents.

Also, analysts polled by Zacks expect revenues of $500.5 million, down 3.1% from the year-ago period.

Fred's, Inc. Price, Consensus and EPS Surprise

Factors Impacting the Quarter

Fred’s has been delivering dismal comps since past many quarters, owing to declining traffic trends, sale of low productive discontinued inventory and rise in generic dispensing rate. Additionally, the company’s store expansion plans were gravely impacted by the cancelled Walgreens Boots Alliance (NASDAQ:WBA) and Rite Aid Corporation (NYSE:RAD) merger in June 2017. Had the deal materialized, Fred’s would have emerged as the third-largest drugstore chain in the nation after Walgreens and CVS Health Corporation (NYSE:CVS) .

We note that comparable store sales dipped 1.2% and 0.3% during the first and second quarters of fiscal 2017. The company’s weak comps trend is likely to continue in the third quarter as well.

Nevertheless, Fred’s has been advancing with initiatives to reduce selling, general and administrative expenses and boost free cash flow. Further, the company has been trying to organize pharmacy business to drive scripts into the stores and improve service to its patients. Although such efforts seem promising, they are yet to bear significant impacts upon the company’s performance.

What Does the Zacks Model Unveil?

Our proven model does not conclusively show that Fred’s is likely to beat earnings estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. You may uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Although Fred’s carries a Zacks Rank #3, its Earnings ESP of 0.00% makes surprise prediction difficult. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Fred's, Inc. (FRED): Free Stock Analysis Report

Rite Aid Corporation (RAD): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

Original post

Zacks Investment Research

Declining Comps Likely To Hurt Fred's (FRED) In Q3 Earnings
 

Related Articles

Declining Comps Likely To Hurt Fred's (FRED) In Q3 Earnings

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email